PPBT ▼ -14.5% - Purple Biotech Ltd $PPBT - Purple Biotech's IM1240, a CAPTN-3-Capped Tri-Specific T- and NK-Cell Engager Targeting 5T4, Shows Robust Tumor Killing in Immunotherapy-Resistant Cancer Models in Plenary Oral Presentation at EORTC-NCI-AACR Symposium 20-NOV-2026 09:00 AM ET